Scholars Central

Review articlePublished 2015

Challenges in the Laboratory Diagnosis and Clinical Management of Heteroresistant Vancomycin Staphylococcus aureus (hVISA)

Authors: Yamuna Devi, Punithavathy PM, Sangeeta Thomas, Balaji Veeraraghavan

Clinical Microbiology: Open Access

Volume 4 · Issue 4 · Pages 1–9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

MRSA is a public health threat and significant cause of health care-associated and community-associated infections. Vancomycin is considered as gold standard in treating life-threatening infections. Recently, reduced vancomycin susceptibility has been reported across the world. However, infection with S. aureus resistant to vancomycin is clinically rare and less relevant in causing infections. The clinical failure of vancomycin therapy is being increasingly reported with vancomycin intermediate S. aureus (VISA) and hetero-resistant vancomycin intermediate S. aureus (hVISA). The therapeutic option in treating hVISA and VISA remains uncertain. Extensive use of vancomycin over a period of time leads to generation of selective pressure and emergence of resistance. In addition, vancomycin has low tissue penetration, slow bactericidal activity and risk of nephrotoxicity. Although, phenotypic feature of VISA and hVISA were well known, their genetic basis remains unknown. VISA and hVISA is generated by the accumulation of mutation leads to thickening of cell wall. Trapping of vancomycin molecule occurs due to the presence of false targets D-ala D-ala residues in the cell wall, before reaching its target site in cytoplasmic membrane. Despite, it is difficult to detect hVISA using standard susceptibility testing methods. Treatment failure is common among patients with high bacterial load infections. Treating of patients with hVISA/ VISA infections is of great challenge for clinicians.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Microbiology: Open Access
  • SubjectMicrobiology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Yamuna Devi”
  • BylineArticles whose byline prints “Punithavathy PM”
  • BylineArticles whose byline prints “Sangeeta Thomas”
  • BylineArticles whose byline prints “Balaji Veeraraghavan”